ABSTRACT
Introduction Mercury poisoning causes hearing loss in humans and animals. Acute and long-term exposures produce irreversible peripheral and central auditory system damage, and mercury in its various forms of presentation in the environment is ototoxic. Objective We investigated the otoacoustic emissions responses in a riverside population exposed to environmental mercury by analyzing the inhibitory effect of the medial olivocochlear system (MOCS) on transient otoacoustic emissions (TEOAE). Methods The purpose of the research was to evaluate the entire community independently of variables of sex and age. All of the participants were born and lived in a riverside community. After otolaryngologic evaluation, participants were received tympanometry, evaluation of contralateral acoustic reflexes, pure tone audiometry, and recording of TEOAEs with nonlinear click stimulation. Hair samples were collect to measure mercury levels. Results There was no significant correlation between the inhibitory effect of the MOCS, age, and the level of mercury in the hair. Conclusions The pathophysiological effects of chronic exposure may be subtle and nonspecific and can have a long period of latency; therefore, it will be important to monitor the effects of mercury exposure in the central auditory system of the Amazon population over time. Longitudinal studies should be performed to determine whether the inhibitory effect of the MOCS on otoacoustic emissions can be an evaluation method and diagnostic tool in populations exposed to mercury. .
Subject(s)
Humans , Spondylarthritis/epidemiology , Africa South of the Sahara/epidemiology , Arthritis, Psoriatic/epidemiology , Arthritis, Psoriatic/genetics , Arthritis, Psoriatic/virology , Arthritis, Reactive/epidemiology , Arthritis, Reactive/genetics , Arthritis, Reactive/virology , Genetic Predisposition to Disease , HIV Infections/complications , /genetics , Spondylarthritis/diagnosis , Spondylarthritis/genetics , Spondylarthritis/virology , Spondylitis, Ankylosing/epidemiology , Spondylitis, Ankylosing/genetics , Spondylitis, Ankylosing/virologyABSTRACT
Presentamos una visión de cómo la concepción de la artritis psoriásica (APs) al unísono ha cambiado con el desarrollo de los conocimientos. Se consolidó tanto el carácter entesopático de la APs que en la estratificación sindromática de la enfermedad se obvia la seronegatividad. Se incrementa la clínica de la APs como es la causalidad del RS3PE en el 21 por ciento, la sacroilitis y la enfermedad intestinal inflamatoria en alto porcentaje (71 y 100 por ciento respectivamente) en psoriasis y APs no axial. Disponemos de medicamentos y tratamientos biológicos que mejoran la calidad de vida de nuestros pacientes, sensibilizándonos a emplearlos tempranamente como en AR